Filtros de búsqueda

Lista de obras de Edouard Louis

A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective

artículo científico publicado en 2020

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

artículo científico publicado en 2019

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

artículo científico

Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial

artículo científico publicado en 2012

Adalimumab in ulcerative colitis: can pharmacodynamics be improved based on pharmacokinetics?

scientific article published on 21 November 2011

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease

artículo científico publicado en 2014

An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

article

Analysis of Genes Associated with Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's disease.

artículo científico publicado en 2018

Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience

artículo científico publicado en 2016

Anti-TNF and Crohn's disease: when should we stop?

artículo científico publicado en 2010

Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level

artículo científico publicado en 2007

Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease

artículo científico publicado en 2015

Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling

artículo científico publicado en 2006

Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up

artículo científico publicado en 2002

CCDC88B is required for pathogenesis of inflammatory bowel disease

artículo científico publicado en 2017

Can we predict the high-risk patient?

artículo científico publicado en 2014

Cancer risk in immune-mediated inflammatory diseases (IMID).

artículo científico publicado en 2013

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

artículo científico publicado en 2009

Characterization of Bacteria in Biopsies of Colon and Stools by High Throughput Sequencing of the V2 Region of Bacterial 16S rRNA Gene in Human ⬇️

artículo científico publicado el 10 de febrero de 2011

Clinical and genetic factors associated with sacroiliitis in Crohn's disease

artículo científico publicado en 2007

Common variants at five new loci associated with early-onset inflammatory bowel disease

artículo científico publicado en 2009

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

artículo científico publicado en 2008

Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis

artículo científico publicado el 22 de abril de 2010

Comparison of two FFPE preparation methods using label-free shotgun proteomics: Application to tissues of diverticulitis patients

artículo científico publicado en 2014

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

artículo científico publicado en 2016

Crohn's Disease Patients' and Gastroenterologists' Perspectives Towards De-Escalating Inflammatory Bowel Disease Therapy: A Comparative European and American Survey

scientific article published on 27 December 2019

Current directions of biologic therapies in inflammatory bowel disease

artículo científico publicado en 2010

De-escalation of immunomodulator and biological therapy in inflammatory bowel disease

artículo científico publicado en 2020

Deep remission: a new concept?

artículo científico

Defining Endoscopic Remission in Ileocolonic Crohn's Disease: Let's Start from Scratch

artículo científico publicado en 2018

Defining the genetic control of human blood plasma N-glycome using genome-wide association study

Defining the genetic control of human blood plasma N-glycome using genome-wide association study

scientific article published on 01 June 2019

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

artículo científico publicado en 2002

Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins

scientific article published on 08 November 2019

Development of the Crohn's disease digestive damage score, the Lémann score

artículo científico publicado en 2010

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases

scientific article published on 31 January 2017

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

artículo científico publicado en 2014

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process

artículo científico

Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts

scientific article published on 26 May 2020

Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis

artículo científico publicado en 2011

Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study

scientific article published on 26 October 2020

Do clinical factors help to predict disease course in inflammatory bowel disease?

artículo científico publicado en 2010

Does the behavior of Crohn's disease change over time?

artículo científico publicado en 2008

Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn's disease?

artículo científico publicado en 2008

Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis

artículo científico publicado en 2011

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study

artículo científico publicado en 2016

Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease

artículo científico publicado en 2013

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

scientific article published on 13 June 2019

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

artículo científico publicado en 2017

Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists.

artículo científico publicado en 2017

Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study

scientific article published on 01 September 2019

Epidemiology of inflammatory bowel diseases in the elderly in the province of Liège

artículo científico publicado en 2002

Erratum: Corrigendum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

scholarly article published in Nature Genetics

European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ('Exit Strategies') in Inflammatory Bowel Disease.

artículo científico publicado en 2017

Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea

artículo científico publicado en 2017

Evolving definitions of remission in Crohn's disease

artículo científico publicado en 2013

Expert consensus: practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies

scientific article published on 25 October 2019

Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease

scientific article published on 20 February 2010

Fine-mapping inflammatory bowel disease loci to single-variant resolution

artículo científico publicado en 2017

Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis

artículo científico publicado en 2009

Genetics of ulcerative colitis: the come-back of interleukin 10

artículo científico publicado en 2009

Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease

artículo científico publicado en 2015

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

artículo científico publicado en 2008

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

artículo científico publicado en 2010

Glucocorticoid-induced leucine zipper (GILZ) is involved in glucocorticoid-induced and mineralocorticoid-induced leptin production by osteoarthritis synovial fibroblasts

scientific article published on 04 October 2016

Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases

artículo científico publicado en 2020

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

artículo científico publicado en 2011

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

artículo científico publicado en 2012

How to Apply for and Secure EU Funding for Collaborative IBD Research Projects

artículo científico publicado en 2016

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.

artículo científico publicado en 2018

Immunogenicity of infliximab: how to handle the problem?

artículo científico publicado en 2007

Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study

artículo científico publicado en 2016

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, or Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.

artículo científico publicado en 2018

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

artículo científico publicado en 2017

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

artículo científico publicado en 2018

Integrated Care for Crohn's Disease: A Plea for the Development of Clinical Decision Support Systems

artículo científico publicado en 2018

Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's Disease

artículo científico publicado en 2016

Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply

scientific article published on 01 November 2020

Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study

scientific article published on 01 October 2019

Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO).

artículo científico

Looking for innovative digital solutions to optimize patient recruitment in IBD trials

artículo científico publicado en 2020

Lymphotoxin alpha gene in Crohnʼs disease patients: absence of implication in the response to infliximab in a large cohort study

article

Magnetic resonance enterography perfusion parameters reveal complex changes in affected and unaffected segments in Crohn's disease

artículo científico publicado en 2020

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

artículo científico publicado en 2011

Making a Case for Case Reports: The ECCO-CONFER Viewpoint on Investigating Rare Events in a Medical World Reigned by Group-comparative Statistics

artículo científico publicado en 2016

Management of inflammatory bowel disease in pregnancy

artículo científico publicado en 2012

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

scientific journal article

Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis

artículo científico publicado en 2015

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease

artículo científico publicado en 2019

Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis

artículo científico publicado en 2008

Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection

artículo científico publicado en 2007

Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.

artículo científico publicado en 2007

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

article

Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosis

artículo científico publicado en 2011

National differences in ulcerative colitis experience and management among patients from five European countries and Canada: an online survey

artículo científico publicado en 2012

Necessity of phenotypic classification of inflammatory bowel disease

artículo científico publicado en 2011

New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools

artículo científico publicado en 2008

No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease

scientific article published on 01 January 2006

Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4

artículo científico publicado en 2007

OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages

artículo científico publicado en 2017

On-site comparison of an enzymatic detergent and a non-enzymatic detergent-disinfectant for routine manual cleaning of flexible endoscopes

scientific article published on 21 March 2019

Optimising monitoring in the management of Crohn's disease: a physician's perspective

artículo científico publicado en 2013

Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations

artículo científico publicado en 2015

Optimizing treatment with thioguanine derivatives in inflammatory bowel disease

artículo científico publicado en 2003

Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission

artículo científico publicado en 2017

Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up

artículo científico publicado en 2016

Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group

artículo científico publicado en 2020

Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey

artículo científico publicado en 2012

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study

artículo científico publicado en 2017

Predictors of severe Crohn's disease

scientific article published on 01 August 2008

Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

artículo científico publicado en 2019

Proteomics Highlights Common and Distinct Pathophysiological Processes Associated with Ileal and Colonic Ulcers in Crohn's Disease

scientific article published on 01 February 2020

Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study

artículo científico publicado en 2008

Reply

artículo científico publicado en 2019

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

scholarly article by Matthieu Allez et al published October 2010 in Journal of Crohn's and Colitis

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease

artículo científico publicado en 2011

Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease

artículo científico

Review article: withdrawal of 5-aminosalicylates in inflammatory bowel disease

scientific article published on 26 May 2020

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.

artículo científico publicado en 2011

Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study

artículo científico publicado en 2018

Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia

scientific article published on 13 June 2019

Risk of Late Post-Operative Recurrence of Crohn's Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers

artículo científico publicado en 2020

Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring

artículo científico

Selective glucocorticoid receptor modulator compound A, in contrast to prednisolone, does not induce leptin or the leptin receptor in human osteoarthritis synovial fibroblasts

artículo científico publicado en 2014

Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease.

artículo científico publicado en 2008

Serum adalimumab concentration and clinical remission in patients with Crohn's disease

artículo científico publicado en 2013

Severe lower gastrointestinal bleeding in Crohn's disease: successful control with infliximab

artículo científico publicado en 2002

Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy

artículo científico publicado en 2010

Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis

scientific article published on 13 September 2020

Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease

artículo científico publicado en 2019

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease

artículo científico

Tailoring the treatment to the individual in Crohn's disease

artículo científico publicado en 2009

The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease

artículo científico publicado en 2020

The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohnʼs disease

article

The c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization process

scientific journal article

The course of anaemia in children and adolescents with Crohn's disease included in a prospective registry

artículo científico publicado en 2014

The role of aminosalicylates in the treatment of ulcerative colitis

artículo científico publicado en 2002

The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13.

artículo científico

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis ⬇️

artículo científico publicado el 15 de enero de 2010

Treatments for Crohn’s Disease–Associated Bowel Damage: A Systematic Review

artículo científico publicado en 2018

Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients

artículo científico publicado en 2017

Use of azathioprine in IBD: modern aspects of an old drug

scientific article published on 18 June 2014

Vaccinations in patients with immune-mediated inflammatory diseases

artículo científico publicado en 2010

What changes in inflammatory bowel disease management can be implemented today?

artículo científico

[Early obstructive colon after treatment of active refractory Crohn's disease with infliximab]

scientific article published on 01 November 2003

[Interest of confocal endomicroscopy for the management of chronic inflammatory bowel disease].

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda